Skip to main content
jeuveau

Now Offering Jeuveau!

We are always looking to add quality treatments to our offerings here at Cherry Bend, and we have recently made the decision to introduce Jeuveau into the mix. This treatment works well for those pesky “11s,” – technically called glabellar lines that form between the eyebrows. As the first FDA- approved alternative to Botox in 10 years, it’s formulated with the latest technology to be safer and more effective than ever.

Why Choose Jeuveau Over Botox?

If you’re familiar with the way Botox works, it won’t be hard to understand Jeuveau treatments. They contain the same active ingredient – botulinum toxin type A. It works by temporarily paralyzing the muscles in the injection area, making them unable to create lines on the face. So, what’s the difference between Botox and Jeuveau then? Evolus, the manufacturer of Jeuveau uses proprietary Hi-Pure technology to produce an extremely pure protein formula. This makes it one of the safest neurotoxin injections available. In addition, it works a little faster – producing dramatic results in just two days as compared to Botox’s 3-5 day timeline. The long lasting formula also allows you to minimize your trips to the office. Most people get just 3 treatments a year!

Where Can It Be Used?

This new formula, dubbed “Newtox” by the aesthetic community, is approved specifically for glabellar lines. It doesn’t have the same versatility as Botox, however it is very effective in its singular application. It quickly smooths away lines between the eyebrows, giving a more youthful appearance. If you struggle with frown lines, it’s worth considering this Botox alternative.

To learn more about Jeuveau and if it might be right for you, schedule a consultation with us today. We can go over the benefits, risks, and reasons why clients are loving it for low maintenance results. You’ll quickly see why we are so excited to add this treatment to our offerings.

Leave a Reply

Your email address will not be published. Required fields are marked *